Drugs / Non-adjuvanted trivalent inactivated subunit influenza vaccine
Non-adjuvanted trivalent inactivated subunit influenza vaccine
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00644059 Comparator | Nov 2007 → Apr 2010 | influenza | Novartis | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Non-adjuvanted trivalent inactivated subunit influenza vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00644059 ↗ |
| Modality | Vaccine | “This study will evaluate the efficacy, safety and immunogenicity of one or two 0.25 mL or 0.5 mL intramuscular injections of an adjuvanted influenza vaccine compared with...” NCT00644059 ↗ |
| Route | Intramuscular | “For both vaccines, either two intramuscular (IM) injections of half dose or one IM injection of full dose” NCT00644059 ↗ |